Overview
Michael Gurbisz practices practicing medicine in Vienna, Austria.
Mr. Gurbisz is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Chronic Myelomonocytic Leukemia (CMML), Mast Cell Activation Syndrome (MCAS), Leukemia, and Systemic Mastocytosis.
He is actively involved in clinical research, co-authoring 12 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Michael Gurbisz
Is Michael Gurbisz a top-rated expert for Chronic Myelomonocytic Leukemia (CMML)?
MediFind is an objective health platform that identifies experts based on real-world data. Michael Gurbisz is classified as an Distinguished expert for Chronic Myelomonocytic Leukemia (CMML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Michael Gurbisz participate in research or clinical trials?
Yes. Michael Gurbisz has published 12 articles and abstracts on conditions like Chronic Myelomonocytic Leukemia (CMML). You can view a list of Michael Gurbisz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Myelomonocytic Leukemia (CMML)Mr. Gurbisz isDistinguished. Learn about Chronic Myelomonocytic Leukemia (CMML).
- Advanced
- Mast Cell Activation Syndrome (MCAS)
- Experienced
- Essential ThrombocythemiaMr. Gurbisz isExperienced. Learn about Essential Thrombocythemia.
- LeukemiaMr. Gurbisz isExperienced. Learn about Leukemia.
- Systemic MastocytosisMr. Gurbisz isExperienced. Learn about Systemic Mastocytosis.